249 related articles for article (PubMed ID: 6092892)
1. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
Evans T; Smith MM; Tanner LI; Harden TK
Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
Evans T; Martin MW; Hughes AR; Harden TK
Mol Pharmacol; 1985 Jan; 27(1):32-7. PubMed ID: 2981400
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
[TBL] [Abstract][Full Text] [Related]
5. Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
Harden TK; Heng MM; Brown JH
Mol Pharmacol; 1986 Sep; 30(3):200-6. PubMed ID: 3018476
[TBL] [Abstract][Full Text] [Related]
6. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
[TBL] [Abstract][Full Text] [Related]
7. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
8. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
9. Adenosine and muscarinic cholinergic receptors attenuate cyclic AMP accumulation by different mechanisms in 1321N1 astrocytoma cells.
Hughes AR; Harden TK
J Pharmacol Exp Ther; 1986 Apr; 237(1):173-8. PubMed ID: 2420967
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin differentiates between two mechanisms of attenuation of cyclic AMP accumulation by muscarinic cholinergic receptors.
Hughes AR; Martin MW; Harden TK
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5680-4. PubMed ID: 6091103
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
12. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
13. [3H]propylbenzilylcholine mustard-labeling of muscarinic cholinergic receptors that selectively couple to phospholipase C or adenylate cyclase in two cultured cell lines.
Liang M; Martin MW; Harden TK
Mol Pharmacol; 1987 Oct; 32(4):443-9. PubMed ID: 3118180
[TBL] [Abstract][Full Text] [Related]
14. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
15. H1-histamine receptors on human astrocytoma cells.
Nakahata N; Martin MW; Hughes AR; Hepler JR; Harden TK
Mol Pharmacol; 1986 Feb; 29(2):188-95. PubMed ID: 2419744
[TBL] [Abstract][Full Text] [Related]
16. Activation of muscarinic cholinergic receptors in mouse neuroblastoma x rat glioma hybrid cells: rapid induction of enhanced capacity of prostaglandin E1 receptors to stimulate cyclic AMP accumulation.
Thomas JM; Hoffman BB
J Pharmacol Exp Ther; 1990 Feb; 252(2):616-22. PubMed ID: 2156056
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
18. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
Tanner LI; Harden TK; Wells JN; Martin MW
Mol Pharmacol; 1986 May; 29(5):455-60. PubMed ID: 2422535
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an agonist-induced, ATP-dependent change in muscarinic receptors of intact 1321N1 cells.
Hoover RK; Toews ML
J Pharmacol Exp Ther; 1989 Oct; 251(1):63-70. PubMed ID: 2795471
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI
J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
